40.1 F
Fort Worth
Monday, October 26, 2020
Health Care Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Other News

By MARILYNN MARCHIONE AP Chief Medical Writer

A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.

Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Its drug is similar to one that President Donald Trump received on Friday from Regeneron Pharmaceuticals Inc. These medicines supply concentrated versions of specific antibodies to help the immune system clear the coronavirus that causes COVID-19. They’re given as a one-time treatment through an IV.

Lilly has already started making one of the two antibodies in its drug, betting that ongoing studies would prove it worthwhile.

It’s not clear if the evidence will be viewed as strong enough for the Food and Drug Administration to grant emergency use authorization, as it has done for the antiviral drug remdesivir.

The results are an interim look at a mid-stage study in which 112 people received the antibodies and 156 got a placebo.

The amount of virus was significantly lower 11 days later in those given the drug — the main goal of the study. Virus also was lower at earlier time points as well. Symptom scores were better at three days.

About 5.8% of patients given placebo required hospitalization or an emergency room visit versus 0.9% of those given the antibodies.

The company said there were no serious drug-related side effects.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Latest News

Fort Worth City Council Preview for Oct. 27

From the City of Fort Worth: The following information is a preview of items being discussed at City...

Care N’ Care Health Plan adds Methodist Medical Group

Care N’ Care (HMO/PPO) Health Plan added Methodist Medical Group into its provider network, effective Nov. 1. The group currently employs 227...

Barrett confirmation vote set for tonight

By LISA MASCARO  AP Congressional Correspondent WASHINGTON (AP) — Overpowering Democratic opposition, Senate Republicans are set to confirm Amy...

US coronavirus deaths rising; El Paso officials say ‘stay home’

By LISA MARIE PANE and MIKE STOBBE Associated Press BOISE, Idaho (AP) — Deaths per day from the coronavirus...

El Paso officials ask residents to stay home for two weeks as COVID-19 hospitalizations surge

By Cassandra Pollock and Julián Aguilar, The Texas Tribune Oct. 25, 2020 "El Paso...